The 6 analysts offering 12-month price forecasts for Kindred Biosciences Inc have a median target of 9.25, with a high estimate of 15.25 and a low estimate of 9.00. The median estimate represents a +0.43% increase from the last price of 9.21.
The current consensus among 7 polled investment analysts is to Hold stock in Kindred Biosciences Inc. This rating has held steady since June, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.